AKUMS DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-52 Cr | ₹1,462 Cr | ₹1,246 Cr | ₹1,153 Cr | ₹685 Cr |
What is the latest Total Non-Current Liabilities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-52 Cr |
| Mar2024 | ₹1,462 Cr |
| Mar2023 | ₹1,246 Cr |
| Mar2022 | ₹1,153 Cr |
| Mar2021 | ₹685 Cr |
How is Total Non-Current Liabilities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-52 Cr | Negative | |
| Mar2024 | ₹1,462 Cr | 17.35 | |
| Mar2023 | ₹1,246 Cr | 8.11 | |
| Mar2022 | ₹1,153 Cr | 68.24 | |
| Mar2021 | ₹685 Cr | - | |
Compare Total Non-Current Liabilities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹7,621.3 Cr | 0.5% | 7.7% | -1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 0.5% |
7.7% |
-1% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses